US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

39.83

-0.1700-0.43%

Post-market: 39.830.00000.00%16:10 EDT

Volume:45.67K

Turnover:1.82M

Market Cap:270.84M

PE:- -

High:40.20

Open:40.12

Low:39.71

Close:40.00

52wk High:41.49

52wk Low:22.33

Shares:6.80M

Float Shares:6.80M

Volume Ratio:0.49

T/O Rate:0.67%

Dividend:0.28

Dividend Rate:0.70%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Moderna Stock (MRNA) Was the Best Performer in August

Revolution Medicines, Inc. : Needham Raises Target Price to $275 from $240

THOMSON REUTERS

Protagonist announces Takeda received U.S. FDA approval for MIMRYLO

Tenax Therapeutics announces results from Phase 3 LEVEL trial of TNX-103

Incyte (INCY) Stock Could Be 31% Stretched Following KRAS Data Buzz

Simply Wall St.

August Turmoil: Bessent's Intervention and the Quiet Reveal of Policy's Hidden Hand

Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Spyre Therapeutics (SYRE)

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO

Takeda receives FDA approval of NDA for Mimrylo

US FDA Approves Takeda, Protagonist's Drug for Rare Blood Cancer

Crinetics Shareholders Approve Vertex Acquisition at Special Meeting

US Stocks Weekly: AI Refuel

Incyte Corp Drops in Volume Surge, Last Down 3.0%

THOMSON REUTERS

BioNTech Stock Falls on Cancer Vaccine Setback Days After Moderna's Big Win

BioNTech on Track for Worst Day Since March After Ending Colorectal Cancer Trial

Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors

Revolution Medicines Set to Post 'Strong Launch' for Rasonque, UBS Says

MT Newswires Live

mRNA immunotherapy discontinuation a negative for BioNTech, says Morgan Stanley

Moderna Stock Falls on $2B Notes Deal: Is the Cancer Rally Still Intact?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/IDNA/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"IDNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","market":"US","secType":"STK","nameCN":"iShares Genomics Immunology and Healthcare ETF","latestPrice":39.83,"timestamp":1789761600000,"preClose":40,"halted":0,"volume":45673,"hourTrading":{"tag":"盘后","latestPrice":39.83,"preClose":39.83,"latestTime":"16:10 EDT","volume":6617,"amount":263555.11,"timestamp":1789762203995,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.004250000000000043,"floatShares":6800000,"shares":6800000,"eps":0,"marketStatus":"Post-Mkt","change":-0.17,"latestTime":"09-18 16:54:47 EDT","open":40.12,"high":40.2,"low":39.7101,"amount":1821020,"amplitude":0.012248,"askPrice":45.38,"askSize":100,"bidPrice":34.02,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789776000000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":40,"sharesOutstanding":5100000,"nav":38.722209,"aum":263311021.2,"dividendRate":0.00703,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":40.9,"preClose":40,"latestTime":"09:14 EDT","volume":25,"amount":1017.07,"timestamp":1789737274853,"change":0.9,"changeRate":0.0225,"amplitude":0.03025},"postHourTrading":{"tag":"盘后","latestPrice":39.83,"preClose":39.83,"latestTime":"16:10 EDT","volume":6617,"amount":263555.11,"timestamp":1789762203995,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.490286,"impliedVol":0.2131,"impliedVolPercentile":0.5458},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","floatShares":6800000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.490286,"shares":6800000,"dividePrice":0.28,"high":40.2,"amplitude":0.012248,"preClose":40,"low":39.7101,"week52Low":22.33,"pbRate":"--","week52High":41.49,"institutionHeld":0,"latestPrice":39.83,"eps":0,"divideRate":0.00703,"volume":45673,"delay":0,"ttmEps":0,"open":40.12,"prevYearClose":26.19,"prevWeekClose":38.06,"prevMonthClose":39.26,"prevQuarterClose":33.75,"fiveDayClose":38.06,"twentyDayClose":39.29,"sixtyDayClose":31.71},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDNA\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IDNA","amount":0.125421,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2025-12-16","symbol":"IDNA","amount":0.155456,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-06-16","symbol":"IDNA","amount":0.152909,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"},{"date":"2024-12-17","symbol":"IDNA","amount":0.11105,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2024-06-11","symbol":"IDNA","amount":0.11144,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-11","defaultRemindTime":1718112600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-17","payableDate":"2024-06-11","currency":"USD","dateTimestamp":1718078400000,"payDate":"2024-06-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDNA\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-16","recordDate":"2019-12-17","paymentDate":"2019-12-20","value":0.237063,"currency":"USD"},{"executeDate":"2020-06-15","recordDate":"2020-06-16","paymentDate":"2020-06-19","value":0.083667,"currency":"USD"},{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-18","value":0.036209,"currency":"USD"},{"executeDate":"2021-06-10","recordDate":"2021-06-11","paymentDate":"2021-06-16","value":0.052145,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-17","value":0.256358,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDNA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDNA\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664200767","title":"Moderna Stock (MRNA) Was the Best Performer in August","url":"https://stock-news.laohu8.com/highlight/detail?id=2664200767","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664200767?lang=en_us&edition=fundamental","pubTime":"2026-09-01 01:18","pubTimestamp":1788196728,"startTime":"0","endTime":"0","summary":"Moderna’s ($MRNA) stock rose 152% in August, making it the best-performing security during the month.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/moderna-stock-mrna-was-the-best-performer-in-august?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/moderna-stock-mrna-was-the-best-performer-in-august?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNA","BK4534","BK4588","MRNY","BK4551","WDNA","BK4585","BK4568","BK4533","BK4548","IDNA","MRNX","BK4532","LGHT","GNOM","BK4501","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663079265","title":"Revolution Medicines, Inc. : Needham Raises Target Price to $275 from $240","url":"https://stock-news.laohu8.com/highlight/detail?id=2663079265","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663079265?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:45","pubTimestamp":1788169510,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S00C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BJJMRZ35.SGD","IE0009354923.USD","BBH","PTH","LU0320765992.SGD","IE0002141913.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","CANC","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","IDNA","IE0009355771.USD","RVMD","LU0889565916.HKD","LU0109394709.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663588047","title":"Protagonist announces Takeda received U.S. FDA approval for MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663588047","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663588047?lang=en_us&edition=fundamental","pubTime":"2026-08-31 04:35","pubTimestamp":1788122107,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics (PTGX) announced that Takeda (TAK) received U.S. Food and Drug Administration, FDA, approval for MIMRYLO, a subcutaneously...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MRNY","BMED","MRNX","IYH","TBXU","TAK","LABU","GDOC","RSPH","TECB","XLVX","MEDI","BK4585","BBP","PTGX","SYNB","GNMX","FRTY","PINK","NVIB","BK4139","LFSC","PSCH","IEIH","IDNA","BK4588","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663404203","title":"Tenax Therapeutics announces results from Phase 3 LEVEL trial of TNX-103","url":"https://stock-news.laohu8.com/highlight/detail?id=2663404203","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663404203?lang=en_us&edition=fundamental","pubTime":"2026-08-31 03:35","pubTimestamp":1788118510,"startTime":"0","endTime":"0","summary":"Tenax Therapeutics (TENX) announced that additional results from the Phase 3 LEVEL clinical trial evaluating TNX-103 in patients with pulmonary hyp...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tenax-therapeutics-announces-results-from-phase-3-level-trial-of-tnx-103-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tenax-therapeutics-announces-results-from-phase-3-level-trial-of-tnx-103-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TENX","LENZ","IDNA","MEDX","BK4139","BK4007","HYLG","GDOC","BK4539","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663562049","title":"Incyte (INCY) Stock Could Be 31% Stretched Following KRAS Data Buzz","url":"https://stock-news.laohu8.com/highlight/detail?id=2663562049","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663562049?lang=en_us&edition=fundamental","pubTime":"2026-08-30 15:21","pubTimestamp":1788074461,"startTime":"0","endTime":"0","summary":"Incyte stock has delivered a strong 92.3% gain over the past three years, yet current valuation checks suggest investors may be paying a premium to the intrinsic value estimate while traditional multiples look more in line with peers. The result is a stock that no longer looks obviously cheap, even after a solid multi year run.\n\nIncyte has returned 92.3% over three years, which puts more pressure on today’s valuation to be supported by future cash flows rather than past share price...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-incy/incyte/news/incyte-incy-stock-could-be-31-stretched-following-kras-data","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-incy/incyte/news/incyte-incy-stock-could-be-31-stretched-following-kras-data","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4550","INCY","BK4588","BK4532","BK4585","IDNA","DCF","BK4139","SPHQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177566071","title":"August Turmoil: Bessent's Intervention and the Quiet Reveal of Policy's Hidden Hand","url":"https://stock-news.laohu8.com/highlight/detail?id=1177566071","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177566071?lang=en_us&edition=fundamental","pubTime":"2026-08-30 13:40","pubTimestamp":1788068423,"startTime":"0","endTime":"0","summary":"August was expected to be a quiet month for markets, yet it has instead become a profound release of policy signals.US Treasury Secretary Scott Bessent has intervened in both the dollar-yen exchange...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GAMR","LU0820561818.USD","IE00BDRTCR15.USD","LU2092937148.SGD","LU0077335932.USD","LU0661504455.SGD","LU2487616109.SGD","LU0553294199.USD","LU0528227936.USD","ANV","LU0061475181.USD","LU2326559502.SGD","LU2506951792.HKD","LU0276348264.USD","ESUM","IGV","LU2106854487.HKD","LU2361045086.USD","LU1066051498.USD","LU2505996509.AUD","LU2413666699.HKD","LU2111349929.HKD","LU0096364046.USD","LFGY","ILDR","IE0034235303.USD","IE00B4JS1V06.HKD","IE00B3SWFQ91.USD","LU2357125470.USD","LU2250418816.HKD","WISE","LU1989772923.USD","LU0203201768.USD","LU2403377893.USD","LU2063271972.USD","LU1323610961.USD","LU0476273544.USD","LU0081259029.USD","2NVD.UK","LU2097344357.USD","LU2168564065.EUR","LU2125154778.USD","LGHT","LU1814569148.SGD","LU0107464264.USD","LU1989764664.SGD","SG9999004303.SGD","LU0267386448.USD","LU1144417596.USD","LU2211815571.USD","LU0289960550.SGD","SGXZ81514606.USD","LU1880398554.USD","BK4568","LU0949170772.SGD","IE00BD6J9T35.USD","LU1923622291.USD","LU2290526834.HKD","LU0143551892.USD","LU2023250330.USD","LU0006306889.USD","IE0003U64NQ7.SGD","LU1400636491.USD","SNVD.UK","LU0345770308.USD","NVIW.SI","TTEQ","SG9999014575.USD","JGRO","SG9999014559.SGD","LU2087625088.SGD","LU1983260115.SGD","LU0109391861.USD","LU0320765059.SGD","LU1267930573.SGD","LU0138981039.USD","LU0072462426.USD","LU2265009873.SGD","LU2458330243.SGD","LU1868837136.USD","LU0795875169.SGD","LU2471134952.CNY","LU0203202063.USD","LU0096362180.USD","BK4551","LU1366192091.USD","LU2168563687.JPY","LU2471134796.USD","LU1815336760.USD","LU1366333091.USD","LU0069063385.USD","07788","LU0689472784.USD","NVC","NVDW","LU0689626769.HKD","LU0057025933.USD","LU1674673428.USD","LU2462591350.SGD","IE00BFSS7M15.SGD","BK4608","IE00BKDWB100.SGD","BK4587","LU1979441026.SGD","BK4532","LU2361044865.SGD","LU1551013425.SGD","SG9999014567.USD","LU0274383776.USD","LU2360106780.USD","LU0466842654.USD","IE0005OL40V9.USD","LU0444973449.USD","LU0211327993.USD","SG9999014898.SGD","LU0912757837.SGD","LU1232071149.USD","IE000ITXATA3.USD","LU2471134523.USD","LU1732800096.USD","LU0642271901.SGD","LU1674673691.USD","LU0323240290.USD","LU1119994496.HKD","SG9999018865.SGD","LU1037948897.HKD","LU1202635105.USD","LU0158827948.USD","BK4548","BK4598","LU0345768740.USD","IE00BN29S564.USD","LU1691799644.USD","LU1868837300.USD","LU1914381329.SGD","LU0823421416.USD","NVDS.UK","FDTX","IE00BJLML261.HKD","LU0786609619.USD","LU0820562030.AUD","LU2360032135.SGD","LU0011850046.USD","IE00B5TLWC47.USD","LU2552382215.SGD","LU1267930730.SGD","MRNA","LU1934455277.USD","LU2552382058.USD","LU2125909593.SGD","LU0158827781.USD","LU1069344957.HKD","LU1917777945.USD","IE00B4YYXB79.USD","LU0266013472.USD","LU0061474705.USD","IE00B775H168.HKD","IE00BQXX3F31.USD","LU0289961442.SGD","LU1035773651.USD","LU2249611893.SGD","LU2213496289.HKD","3NVD.UK","VGT","LU0964807845.USD","LU0820561909.HKD","LU1127390331.HKD","LU1712237335.SGD","BK4614","LU2452424414.USD","SG9999015945.SGD","LU1821325948.USD","LU0726765562.USD","LU1037948541.HKD","IE00B3M56506.USD","LU0557290698.USD","LU1934455194.USD","LU0056508442.USD","LU1804176565.USD","LU2602419157.SGD","LU0256863811.USD","HK0000306685.HKD","LU2272731600.USD","LU2381873111.SGD","NVDU","IE00BMPRXN33.USD","LU1242518857.USD","LU2237443382.USD","LU0511384066.AUD","LU0109392836.USD","LU1153585028.USD","LU1261432733.SGD","IE00B5949003.HKD","LU0029864427.USD","LU0210533765.USD","LU0868494708.USD","LU2028103732.USD","LU2264538146.SGD","LU1116320901.HKD","LU0640476718.USD","LU2279689827.SGD","LU2236285917.USD","TRFK","LU3102509885.SGD","LU2430703095.HKD","LU2756315318.SGD","SG9999015978.USD","LU1267930490.SGD","LU2065171402.SGD","NVDY","LU2168564495.EUR","LU2458330169.SGD","LU2473716301.USD","XLK","LU2244417387.USD","LU2552382132.HKD","SG9999000418.SGD","IE0009G5SDU7.USD","WDNA","LU0348723411.USD","IE00B19Z8X17.USD","NVDG","LU0395794307.EUR","NULC","LU2491049909.HKD","LU1923622614.USD","07388","LU2083900584.USD","CLSE","LU2430703178.SGD","BK4592","LU0323591593.USD","NVDL","LU2272731782.SGD","LU0174119429.USD","SG9999014542.SGD","LU2125154935.USD","LU0943347566.SGD","LU2430703251.USD","BK4141","LU1951198990.SGD","BK4579","IE00BYXW3230.USD","IE0034235295.USD","VT","BK4501","SG9999014880.SGD","LU2089985449.USD","LU0256863902.USD","LU2065171311.SGD","LU2505996681.GBP","LU0672654240.SGD","TEK","SHOC","LU1244550221.USD","LU0823414551.USD","LU2023250504.SGD","LU1935043023.USD","LU2237957811.SGD","AIFD","IE00BJTD4N35.SGD","LU0417517546.SGD","LU2361044949.HKD","LU2456880835.USD","LU1732799900.SGD","LU1974910355.USD","LU1880398471.USD","IE00BK4W5L77.USD","SG9999001424.SGD","IE00B19Z9505.USD","MRNX","LU2100268510.USD","LU1670756490.USD","LU0316494557.USD","LU2133065610.SGD","LU0965509010.AUD","LU0868494617.USD","IE00BZ199S13.USD","LU2089283258.USD","LU0170899867.USD","LU1244550577.SGD","SG9999015358.SGD","NVII","LU0545039389.USD","IE00BMPRXQ63.HKD","LU0345769631.USD","NVDO","LU0708994859.HKD","LU1066053197.SGD","LU2491050071.SGD","LU1988902786.USD","IE00BJJMRY28.SGD","LU2931357623.SGD","LU0234572021.USD","METV","IE00BMPRXR70.SGD","LU1429558221.USD","LU1791710582.SGD","LU2168564149.EUR","NVYY","SG9999014906.USD","LU1633808545.USD","LU1868836914.USD","LU0238689110.USD","LU2125909916.SGD","LU0225283273.USD","LU0345770993.USD","LU0342679015.USD","LU0133085943.USD","LU2461242641.AUD","LU2417539215.USD","BK4534","IE00BQXX3C00.GBP","LU1400636574.HKD","LU2023251221.USD","IE000W1ABFV2.USD","LU2357305700.SGD","BK4543","BK4567","IXN","CNEQ","SG9999015952.SGD","LU0070217475.USD","IE00BKPKM429.USD","LU2272731865.HKD","IE00BQXX3D17.EUR","LU1116320737.USD","LU1496350171.SGD","CMAG","LU0323239441.USD","LU0683600562.USD","LU1629891620.HKD","SG9999017495.SGD","BK4533","SNVDAmain","LU1720051108.HKD","NVD3.UK","LU0310799852.SGD","LU0889565833.HKD","LU1992135399.USD","SOXX","BK4549","LU0106261372.USD","LU2077746001.SGD","LU0094547139.USD","LU0124676726.USD","BK4588","LU1861220033.SGD","ROM","LU0965509101.SGD","NVDS","LU2543165471.USD","MRNY","EFIV","BK4581","LU1084165304.USD","LU0187121727.USD","LU0738911758.USD","LU0053666078.USD","LU1003077747.HKD","LU2148611432.USD","LU1923623000.USD","LU2471134879.HKD","CHPX","LU0823434583.USD","IE00BJTD4V19.USD","IE00BKVL7J92.USD","NVD2.UK","TYLG","SNPE","LU1861127337.USD","IE0004445239.USD","LU0345769128.USD","LU1244550494.USD","LU0061474960.USD","HK0000320264.USD","LU2360107168.USD","LU0882574139.USD","LU2097344431.USD","AIPI","USXF","IE00BZ1G4Q59.USD","LU2294711713.HKD","LU1069347547.HKD","LU2322448791.USD","LU2092627202.USD","LU0985320562.USD","BK4554","IE00B1XK9C88.USD","IETC","IE000Q6AESB8.SGD","LU2125909759.SGD","LU0823414478.USD","LU0979878070.USD","LU2237443465.HKD","SGXZ31699556.SGD","LU0708995401.HKD","LU1868836757.USD","LU0957808578.USD","BK4527","IE00B1BXHZ80.USD","LU0719512351.SGD","LU2347655073.USD","LU0234570918.USD","LU0788109477.HKD","LU2237957902.USD","LU2860962120.EUR","BK4139","LU1316542783.SGD","HK0000304805.HKD","LU0787776722.HKD","IE00B19Z8W00.USD","IE00BWXC8680.SGD","LU0965509283.SGD","AGOX","LU0861579265.USD","LU0097036916.USD","LU2347655156.SGD","LU1721428933.USD","LU0211328371.USD","DIPS","IE0034235188.USD","LU2592432038.USD","LU1992135472.HKD","IE00BJJMRX11.SGD","IE000KEQY171.SGD","LU0354030438.USD","LU1803068979.SGD","LU1778281490.HKD","SMHX","LU1551013342.USD","LU2108987350.USD","NVDD","SMH","LU2750360641.GBP","LU1496350502.SGD","LU2065170008.USD","IE0004445015.USD","LU1066051225.USD","HK0000304797.USD","LU1400636657.SGD","LU2247934214.USD","LU1066051811.HKD","LU1623119135.USD","LU2954938101.SGD","BK4529","FAI","HK0000306701.USD","LU2087621335.USD","LU2756315664.SGD","LU0494093205.USD","BK4585","LU0079474960.USD","LU0128525929.USD","LU0353189680.USD","LU1935042215.USD","SGXZ99366536.SGD","GB00BDT5M118.USD","LU2168564222.USD","LU0080751232.USD","LU2999663052.SGD","BK4612","HK0000532082.HKD","IE0001KFT4U8.USD","LU1720051017.SGD","LU1242518931.SGD","ABFL","IE00BK4W5M84.HKD","LU0265550359.USD","LU0347712357.USD","LU2420271590.USD","LU1280957306.USD","GNOM","NVDQ","LU0472753341.HKD","LU1935042991.SGD","BK4550","LU1645745479.HKD","LU0157215616.USD","LU1791710400.SGD","LU2089284900.SGD","LU1435385759.SGD","LU1571399168.USD","THMR","LU2491050154.USD","LU2237438978.USD","LU2750360997.AUD","LU2462157665.USD","LU1548497426.USD","LU2242650005.HKD","SG9999014914.USD","BK4605","LU0127658192.USD","IE00B775SV38.USD","LU0823434740.USD","LU1815333072.USD","LU0795875086.SGD","LU0823421333.USD","LU2746668974.SGD","SPTE","LU0198837287.USD","TTXU","IE00BDCRKT87.USD","LU0251132253.USD","LU0289739343.SGD","LU0390134368.USD","LU1934455863.HKD","LU2322448957.HKD","LU2237443978.SGD","LU0354030511.USD","LU0048584097.USD","LU1064131342.USD","LU1718418525.SGD","LU0082616367.USD","LU2286300806.USD","IE0009356076.USD","LU2746668461.USD","IDNA","LU1839511570.USD","LU1935043536.SGD","LU2463028550.USD","IE00BFSS8Q28.SGD","IE0004086264.USD","LU0310800379.SGD","LU2237443549.SGD","LU1852331112.SGD","SOXY","LU2637965513.SGD","LU1861215975.USD","LU2125909247.SGD","LU0215105999.USD","LU2237443622.USD","LU2065169927.USD","SOXQ","LU1642822529.SGD","SGXZ23171101.USD","LU0965508806.USD","LU2462591277.SGD","LU2413666426.HKD","LU0942090050.USD","SGXZ80539844.SGD","HK0000914660.USD","IE00B3S45H60.SGD","LU0308772762.SGD","NVDB","IE0004091025.USD","HK0000914686.HKD","SGXZ51526630.SGD","LU2896262040.SGD","SG9999015986.USD","LU2394011477.USD","LU0265550946.USD","ESLG","IE00BHPRN162.USD","NVDA","HK0000819398.USD","LU0154236417.USD","LU0210528500.USD","LU1699723380.USD","HK0000320223.HKD","LU0353189763.USD","LU2054465674.USD","IE00B7KXQ091.USD","LU0345768153.USD","LU2191332357.HKD","LU1951200564.SGD","LU1989772840.SGD","LU0724617625.USD","LU0957791311.USD","LU1935042488.USD","FTEC","SG9999018857.SGD","SG9999002224.SGD","USD","NVD","IE000YTNTUN2.SGD","SG9999015341.SGD","LU1145028129.USD","LU1868836591.USD","NVDX","LU0444971666.USD","LU1035775433.USD","LU2433249047.HKD","BK4503","LU0210536198.USD","LU1989764748.USD","LU2047632596.USD","LU2242649171.HKD","LU0175139822.USD","LU2237443895.HKD","SG9999002232.USD","LU2271345857.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663464017","title":"Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Spyre Therapeutics (SYRE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2663464017","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663464017?lang=en_us&edition=fundamental","pubTime":"2026-08-29 22:30","pubTimestamp":1788013830,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and Spyre Therapeutics (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0029874061.USD","LABU","IE00BJT1NW94.SGD","XBI","XLV","CANC","LU0128526141.USD","BK4588","SYRE","LFSC","IE0009354923.USD","LU0889565916.HKD","BBH","BK4581","PTH","LU0109394709.USD","BK4137","IE00B2B36J28.USD","HCSG","RVMD","BK4139","IE0002141913.USD","BK4585","IE00BFTCPJ56.SGD","LU0320765992.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663019778","title":"Pharma Industry Stares Down Biggest Patent Cliff in Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2663019778","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663019778?lang=en_us&edition=fundamental","pubTime":"2026-08-29 09:00","pubTimestamp":1787965200,"startTime":"0","endTime":"0","summary":"Most companies sell a hit product for as long as customers want it. For drugmakers, a clock starts before a drug is even approved: Patents run out, lower-priced copycats flood in and sales collapse. B","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2168564065.EUR","LU2023250843.SGD","LU0912757837.SGD","LU0672654240.SGD","BK4501","SG9999002224.SGD","LU1712237335.SGD","SG9999015986.USD","LU1974910355.USD","IE0009354923.USD","LU0006306889.USD","LU0320765992.SGD","LU1093756325.SGD","LU1261432733.SGD","LU2237438978.USD","LU1232071149.USD","LU0237698245.USD","IE0009355771.USD","SG9999018865.SGD","LU2129689514.USD","IE00BVYPNV92.GBP","LU0545039389.USD","LU1244550221.USD","LU0316494557.USD","LU0109394709.USD","LU1883839398.USD","IE00BJT1NW94.SGD","BK4585","GDOC","LU0109391861.USD","IE00BK4W5L77.USD","LU1162221912.USD","IE00BLSP4452.SGD","LU2347655073.USD","IE00BN29S564.USD","BK4588","IE000M9KFDE8.USD","LU0868494617.USD","LU0882574055.USD","IE00B2B36J28.USD","LU2168564495.EUR","LU2023250504.SGD","LU2361045086.USD","BK4533","LU1732799900.SGD","LU0225771236.USD","IE00BGHQF631.EUR","LU1267930573.SGD","TRUH","BK4139","BK4551","LU2324357040.USD","NVO","LU0640476718.USD","SG9999015358.SGD","SG9999015978.USD","LU2471134952.CNY","SG9999014914.USD","IE00B1BXHZ80.USD","LU0203202063.USD","LU1069347547.HKD","LU2471134523.USD","LU2236285917.USD","LU1814569148.SGD","LU1116320737.USD","LU1571399168.USD","IE00B42XCP33.USD","BK4007","LU0466842654.USD","LU0980610538.SGD","LU0964807845.USD","LU0648001328.SGD","IE0002141913.USD","LU0130517989.USD","LU2347655156.SGD","LU0868494708.USD","LU0689626769.HKD","LU2129689431.USD","LU2108987350.USD","ELIS","LU1032466523.USD","JDOC","LU1236620750.USD","LU2211815571.USD","LU2237443382.USD","LU2168564149.EUR","LU0211328371.USD","LU1430594728.SGD","LU0289739343.SGD","LU0310799852.SGD","ILDR","LU0079474960.USD","LU0949170772.SGD","LU0320765646.SGD","LU0266013472.USD","LU1839511570.USD","LU0726765562.USD","IE00BKVL7J92.USD","LU0058720904.USD","LU0661504455.SGD","SG9999001176.USD","LU0265550359.USD","LU0154236417.USD","LU0323591593.USD","LU0133085943.USD","IE00BLSP4239.USD","LU0395794307.EUR","LU1868836591.USD","NVOH","LU2168564222.USD","IE00BK4W5M84.HKD","LU0094547139.USD","LU1670711040.USD","LU2756315664.SGD","MRNA","IE00B19Z3581.USD","LU0256863811.USD","LU2471134796.USD","NVOC","FHLC","LU1804176565.USD","IE00BKPKM429.USD","LU0985320562.USD","LU1691799644.USD","LU2361044949.HKD","LU1720051108.HKD","IE0004445239.USD","LU2237443978.SGD","LU0456855351.SGD","OZEM","LU0208291251.USD","IE00B4JS1V06.HKD","LU0820562030.AUD","BBH","LU0289739699.SGD","LU2087625088.SGD","LU0210536198.USD","LU0320765489.SGD","LU1093756168.USD","LU2242646821.SGD","LU0130102774.USD","LU0820561909.HKD","IHE","SGXZ99366536.SGD","HRTS","LU0057025933.USD","LU0477156953.USD","IE00BFSS8Q28.SGD","LU1323610961.USD","LU0234572021.USD","LU1623119135.USD","IE00BBT3K403.USD","LU0786609619.USD","THNR","LU0070302665.USD","LU0354030511.USD","LU2089283258.USD","LU0198837287.USD","IE0000B7K699.USD","LU1934455277.USD","LU1979441026.SGD","IE00B3PB1722.GBP","LU0385154629.USD","LU1551013342.USD","LU1585245621.USD","BMED","LU0708995401.HKD","LU0859254822.USD","LU2552382132.HKD","LU0225283273.USD","LU0289961442.SGD","LU0211331839.USD","SG9999003800.SGD","LU0417517546.SGD","BK4568","LU0861579265.USD","SG9999015341.SGD","LU1066051225.USD","LU0683600562.USD","LU0965509283.SGD","RXL","LU0211327993.USD","SGXZ51526630.SGD","MEDI","IE00BSNM7G36.USD","LU2468319806.SGD","LU0787776722.HKD","LU0965509101.SGD","LU0942090050.USD","IE0005OL40V9.USD","LU2112291526.USD","LU0795875169.SGD","LU1941712264.USD","IE00BJLML261.HKD","LU0965509010.AUD","LU1934455194.USD","LU0553294199.USD","LU1116320901.HKD","LU0345770308.USD","LU2129689605.HKD","PTH","LU1868837300.USD","ELIL","IE00BJJMRX11.SGD","SG9999001176.SGD","LU1244550577.SGD","LU0203345920.USD","LU1069344957.HKD","LU0158827781.USD","LU0029864427.USD","SG9999014880.SGD","LU1496350171.SGD","LU0823416689.USD","IE00BWXC8680.SGD","LU0174119429.USD","MHIP","LU2087621335.USD","LU0321505439.SGD","LU1720051017.SGD","SG9999015952.SGD","LU0069063385.USD","LU2462591350.SGD","LU1989771016.USD","AGNG","LU1061106388.HKD","LU1929549753.HKD","LU0823434740.USD","LU2456880835.USD","BK4566","LU0238689110.USD","LU2471134879.HKD","BK4532","LU0965508806.USD","SG9999014567.USD","LU1551013425.SGD","LU2433249047.HKD","LU1291159041.SGD","LU1066053197.SGD","IE00BZ1G4Q59.USD","BK4581","IE000WAW04H5.SGD","LU0124676726.USD","IE000MB6IJN5.SGD","LU0689472784.USD","BMY","LU2023250330.USD","LU1670627923.USD","LU2746668461.USD","LU1035775433.USD","LU0267386448.USD","BK4516","LU1280957306.USD","LU0203347892.USD","LU1066051498.USD","LU1917777945.USD","SG9999014559.SGD","PPH","LU1037948541.HKD","GLAM","PAWZ","SG9999014575.USD","LU2750360997.AUD","LU1057294990.SGD","SG9999013999.USD","LU1267930730.SGD","LU2756315318.SGD","BK4534","LGHT","LU1267930490.SGD","IXJ","IE0002270589.USD","SG9999011175.SGD","LU2237443549.SGD","IE00B4R5TH58.HKD","LU2491049909.HKD","MRK","IE00BDGV0183.EUR","LU2133065610.SGD","IE00BFXG1179.USD","CANC","BK4599","LU0306806265.USD","LU2106854487.HKD","LU1941712348.USD","LU2264538146.SGD","LU1934455863.HKD","LU2357305700.SGD","LU1983299246.USD","MRNX","LLYZ","IE00BKDWB100.SGD","LU1670628061.USD","LU1548497426.USD","LU0471298777.SGD","LU1074936037.SGD","IYH","LU1064131342.USD","XLV","LU0432979614.USD","LU1244550494.USD","LU1066051811.HKD","LU2552382215.SGD","LU1629891620.HKD","LU1366192091.USD","GNOM","LU2125909247.SGD","LU2461242641.AUD","LU2491050071.SGD","IE00B1XK9C88.USD","LLY","LU1145028129.USD","SG9999017495.SGD","IE00BJJMRZ35.SGD","LU0114720955.EUR","LU1989772923.USD","SG9999018857.SGD","LU0256863902.USD","LU2023251221.USD","SG9999001440.SGD","WDNA","IE00B7KXQ091.USD","LU2746668974.SGD","LU1718418525.SGD","LU0472753341.HKD","IE00BFTCPJ56.SGD","LU0310800379.SGD","LU0708994859.HKD","SG9999014906.USD","LU0098860793.USD","RVMD","LU2213496289.HKD","LU2125154778.USD","IE00B19Z3B42.SGD","LU2237443622.USD","ABBV","LU2462157665.USD","IE00B775H168.HKD","LLYX","LU1496350502.SGD","LU0823434583.USD","BK4550","LU1023059063.AUD","LU2602419157.SGD","SG9999015945.SGD","LU0170899867.USD","LU1201861249.SGD","LLII","LU0128525929.USD","LU1035773651.USD","LU0345770993.USD","LU0234570918.USD","IE000BZT7R73.USD","SGXZ31699556.SGD","SGXZ81514606.USD","GB00BDT5M118.USD","IE0004445015.USD","LU0306807586.USD","LU1699723380.USD","LU2360032135.SGD","SG9999002232.USD","LU0353189680.USD","LU2168563687.JPY","LU2271345857.HKD","LU1868836757.USD","LU2063271972.USD","LU2125909593.SGD","CURE","LU1923622614.USD","LU2552382058.USD","LU2417539215.USD","LU2265009873.SGD","IE000F7OJYX1.SGD","IE00BFSS7M15.SGD","LU1868837136.USD","LU2491050154.USD","LU0106261372.USD","LU0320765059.SGD","LU0203201768.USD","LU2596442595.SGD","BK4548","LU0265550946.USD","LU0985481810.HKD","LU1003077747.HKD","SGXZ57979304.SGD","LU0795875086.SGD","LU1868836914.USD","LU0354030438.USD","LU0061475181.USD","IE000SO60NU8.SGD","LU0820561818.USD","NVOX","SG9999014898.SGD","VHT","LU0097036916.USD","LU2237443465.HKD","LU2125154935.USD","LU0321505868.SGD","MRNY","LU1127390331.HKD","LU2237443895.HKD","IE00BJJMRY28.SGD","LU1989772840.SGD","LU0882574139.USD","LU1670710588.SGD","LU2089984988.USD","LU2360106947.USD","LU2896262040.SGD","LU0943347566.SGD","LU0511384066.AUD","LU1732800096.USD","LU2750360641.GBP","LU0158827948.USD","LU0225284248.USD","LU0122379950.USD","LU1037948897.HKD","LU1670711123.USD","PJP","LU2028103732.USD","LU1988902786.USD","LU2361044865.SGD","LU2242652126.USD","TMED","LU0889565916.HKD","IE00BVYPNW00.USD","LU0096364046.USD","LU2089284900.SGD","LU1670710661.SGD","IDNA","BK4559","LU0353189763.USD","LU0471298694.HKD","LU1236620834.HKD","LU2357627491.SGD","LU0738911758.USD","MEDX","IE00BN8TJ469.HKD","SG9999014542.SGD","LU2111349929.HKD","FTXH","IE0001KFT4U8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663019703","title":"Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663019703","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663019703?lang=en_us&edition=fundamental","pubTime":"2026-08-29 08:52","pubTimestamp":1787964735,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Co ( ($JP:4502) ) just unveiled an announcement. Takeda has secured U.S. FDA approval for MIMRYLO (rusfertide), a first-in-cl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSCH","GNMX","GDOC","NVIB","PINK","MRNX","MRNY","BK4585","IDNA","FRTY","MEDI","XLVX","RSPH","SYNB","BMED","BK4588","BBP","IEIH","IYH","LFSC","TBXU","LABU","IBB","TECB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016033","title":"Takeda receives FDA approval of NDA for Mimrylo","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016033","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663016033?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:00","pubTimestamp":1787958013,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced U.S. FDA approval of the New Drug Application for Mimrylo for the treatment of erythrocytosis in adults with polycythemia ve...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","IBB","RSPH","BBP","NVIB","GDOC","XLVX","BK4007","BK4585","MRNX","TBXU","TAK","GNMX","LFSC","PINK","TECB","IEIH","FRTY","IYH","IDNA","LABU","MEDI","SYNB","BMED","MRNY","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663201572","title":"US FDA Approves Takeda, Protagonist's Drug for Rare Blood Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2663201572","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663201572?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:37","pubTimestamp":1787953064,"startTime":"0","endTime":"0","summary":"US FDA approves Takeda, Protagonist's drug for rare blood cancerAug 28 (Reuters)-The U.S. Food and Drug Administration hasapproveda first-of-its-kind drug from Takeda Pharmaceutical4502.Tand Protagonist TherapeuticsPTGX.Oto treat a rare blood cancer,the health regulator said on Friday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL4N44P1MY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","IDNA","INCY","PTGX","BK4139","BK4585","BK4550","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663015099","title":"Crinetics Shareholders Approve Vertex Acquisition at Special Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015099","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015099?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:33","pubTimestamp":1787952818,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals ( ($CRNX) ) has provided an update. On August 28, 2026, Crinetics Pharmaceuticals shareholders held a special meeting at ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/crinetics-shareholders-approve-vertex-acquisition-at-special-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/crinetics-shareholders-approve-vertex-acquisition-at-special-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","LU0757428866.USD","LU1778281490.HKD","LU0256863811.USD","LU2324357040.USD","IE0002141913.USD","LU0823416689.USD","BBH","IE00BJT1NW94.SGD","LU0432979614.USD","LU1674673428.USD","IE00B894F039.SGD","BK4023","IE00B19Z3B42.SGD","IE00BZ9MQY76.HKD","BK4588","BK4567","LU2362540622.SGD","LU2417539215.USD","LU2236285917.USD","IE00BFTCPJ56.SGD","IDNA","LU1815336091.USD","BK4585","VERX","IE00BJJMRZ35.SGD","LU2462157665.USD","LU0234570918.USD","LU1674673691.USD","SG9999001176.SGD","BIB","IE00B19Z3581.USD","PBE","GNMX","LU0320765992.SGD","LU0566484027.USD","LU1069344957.HKD","BK4533","LU1093756168.USD","LU0289739699.SGD","LU0079474960.USD","LU1430594728.SGD","IBBQ","IE00B19Z9P08.USD","VRTX","LU2468319806.SGD","TBXU","LU0061475181.USD","IBB","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663015350","title":"US Stocks Weekly: AI Refuel","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015350","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015350?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:40","pubTimestamp":1787949646,"startTime":"0","endTime":"0","summary":"BUZZ-US stocks weekly: AI refuel** S&P 500.SPXgains 0.5% with all eyes glued to AI bellwether Nvidia and Jackson Hole.N** Dow.DJIup 0.5%, Nasdaq Composite.IXICadvances 0.8%** S&P 500 bullsfocus onkey ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL6N44P0TC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4527","BK4529","LU2168564222.USD","LU2023250504.SGD","LU0345768153.USD","LU2237957811.SGD","LU2357125470.USD","LU1815336760.USD","AIPI","LU0310799852.SGD","IE00B19Z8X17.USD","IE00B3SWFQ91.USD","LU0345769128.USD","LU2237443622.USD","LU2360106780.USD","LU2487616109.SGD","LU2471134952.CNY","LU2458330243.SGD","NKE","LU0689472784.USD","BK4568","IE00BFSS7M15.SGD","LU2100268510.USD","LU0683600562.USD","LU0965509010.AUD","LU1435385759.SGD","LU1670710661.SGD","LU1235294995.USD","IE00BFXG0V08.USD","NVDQ","LU0477156797.USD","LU1720051017.SGD","LU1804176565.USD","IE00BKVL7J92.USD","ANV","LU2148611432.USD","LU1839511570.USD","LU0061474705.USD","CIBR","NVIW.SI","CRM","LU1119994496.HKD","LU1201861165.SGD","LU0061475181.USD","LU1400636491.USD","IETC","LU2237438978.USD","LU2242649171.HKD","LU2394011477.USD","HK0000320264.USD","LU0081259029.USD","SPXU","LU2756315664.SGD","OGIG","LU1323610961.USD","XYLD","BK4592","LU0316494557.USD","LU1046421795.USD","CHPX","LU2279689827.SGD","LU0210528500.USD","SDS","LU0149725797.USD","LU0276348264.USD","LU2023250330.USD","SPY","GB00B4LPDJ14.GBP","IE00B3M56506.USD","CRMG","ESUM","SNVDAmain","SOXQ","SPYG","LU2552382058.USD","LU2347655156.SGD","ILDR","LU2505996681.GBP","SGXZ51526630.SGD","FBYY","IE00B4JS1V06.HKD","PSWD","IE0009G5SDU7.USD","LU1861217088.USD","LU0133085943.USD","RSPN","LU2213496289.HKD","LU1564329461.SGD","LU1059921491.USD","IVW","META","LU0552385451.USD","LU0661504455.SGD","LU1778281490.HKD","SG9999014914.USD","SG9999014880.SGD","LU2249611893.SGD","LU1400636574.HKD","LU2065169927.USD","BK4548","LU1670756490.USD","BK4567","HK0000320223.HKD","LU1037948897.HKD","BK4023","LU0949170772.SGD","VBK","LU0130517989.USD","IE0004086264.USD","LU0274383776.USD","LU2452424414.USD","STYL","LU1301847155.USD","BK4561","SPXL","BK4507","LU1992135472.HKD","LU0128525689.USD","LU1202635105.USD","SPUU","LU1267930227.SGD","JEPI","LU2592432038.USD","IE00BZ9MQY76.HKD","LU0889566641.SGD","LU1983260115.SGD","LU0048584097.USD","LU0320765059.SGD","LU2237443465.HKD","BK4585","IE00BN29S564.USD","LU0097036916.USD","LU0128525929.USD","NVD","IE00BMPRXN33.USD","LU0965508806.USD","LU2125909916.SGD","IE00B894F039.SGD","LU0251131958.USD","SPYM","LU2458330169.SGD","BK4579","LU0094547139.USD","LU1791710400.SGD","LU2361044865.SGD","NVDY","NVYY","LU2168564495.EUR","BK4560","LU0823414551.USD","SPLV","LU0390134368.USD","LU2063271972.USD","LU2083900584.USD","SG9999014906.USD","IJR","RSPA","LU0052756011.USD","LU0174119429.USD","LU0256863811.USD","UPRO","NVDB","SG9999014542.SGD","LU1642822529.SGD","LU2404859667.USD","SH","IE00BK4W5M84.HKD","LU1861220207.SGD","LU2552382132.HKD","BK4139","07388","3NVD.UK","SCHB","USD","DKS","BK4549","LU0348723411.USD","LU0878866978.SGD","VT","IVE","BK4141","LU0310800379.SGD","SG9999015978.USD","CRWL","LU0792757196.USD","PYPU","SPMO","LU0494093205.USD","LU1303367103.USD","LU2097829019.USD","TYLG","LU1691799644.USD","IE0034235303.USD","LU0211331839.USD","SG9999002232.USD","TSPY","LU1400636657.SGD","LU2097344357.USD","LU1429558221.USD","NVDL","VEU","LU2756315318.SGD","ACWI","HK0000532082.HKD","LU2413666699.HKD","LU2491050071.SGD","LU2764263039.SGD","METD","LU0786609619.USD","SG9999000418.SGD","HIBL","FCOM","LU0143551892.USD","LU2462591350.SGD","GNOM","FINX","LU0823434583.USD","LU1267930490.SGD","LU2403377893.USD","LU0006306889.USD","SPAM","LU0079474960.USD","LU1935043023.USD","LU2211815571.USD","LU2637965513.SGD","FDTX","LU0472753341.HKD","LU2125909593.SGD","LU2404859741.USD","LU0345769631.USD","IPAY","TRFK","XDAT","LU0964807845.USD","SPTE","LU1623119135.USD","BK4106","LU0345768740.USD","IE00B775H168.HKD","RSPU","ETFT","DIPS","HK0000306685.HKD","LU2543165471.USD","LU2286300806.USD","SG9999001424.SGD","STBQ","XLK","SG9999015945.SGD","LU0069063385.USD","IE00B19Z3581.USD","SG9999018857.SGD","LU1069344957.HKD","VOX","LU1564329115.USD","LU2272731865.HKD","LU0347712357.USD","LU1935043536.SGD","LU2317271919.USD","ROM","IE0009356076.USD","WDNA","LU1496350502.SGD","IE00BKDWB100.SGD","LU2271345857.HKD","LU1720051108.HKD","LU0251142724.SGD","LU1699723380.USD","IE0034235188.USD","LU2272731600.USD","LU0708994859.HKD","NVDO","BK4607","LU1645745479.HKD","LULU","IGV","NVC","SPYH","LU2237443382.USD","LU2506951792.HKD","LU0640476718.USD","SG9999004303.SGD","LU0070302665.USD","LU0154236417.USD","LU0690374615.EUR","LU0719512351.SGD","LU1267930730.SGD","LU2125909247.SGD","LU0882574139.USD","LU2168563687.JPY","LU2265009873.SGD","LU0354030511.USD","LU0056508442.USD","LU1232071149.USD","IE00B19Z9P08.USD","IE00BZ1G4Q59.USD","LU0106261372.USD","LU0528227936.USD","LU1551013425.SGD","NVDS.UK","BK4503","BUG","USXF","LU2456880835.USD","LU1934455863.HKD","LU1670628061.USD","LU0310800965.SGD","BK4528","LU1035773651.USD","LU2430703251.USD","SFY","IE00BWXC8680.SGD","SOXX","IE00BQXX3D17.EUR","SG9999014898.SGD","LU2999663052.SGD","LU1064131342.USD","RSP","SSO","VOO","CRWD","LU1037948541.HKD","LU0353189763.USD","CRWC","THMR","LU0942090050.USD","LU1069347547.HKD","LU1280957306.USD","FBY","HK0000914686.HKD","LU0889565833.HKD","LU2077746001.SGD","BK4534","LU1721428933.USD","PYPL","LU0077335932.USD","LU0726765562.USD","LU0724617625.USD","BK4598","SGXZ23171101.USD","LU2896262040.SGD","LU0238689110.USD","SPYQ","LU2054465674.USD","LU0011850046.USD","LU2098885051.SGD","LU2471134796.USD","LU2326559502.SGD","LU2089284900.SGD","SNVD.UK","BK4543","LU0162691827.USD","BK4605","LU1242518857.USD","LU0211327993.USD","LU1803068979.SGD","LU1116320901.HKD","LU0107464264.USD","LU1935042991.SGD","CLOD","IE00B1XK9C88.USD","IE0005OL40V9.USD","FBX","LU0795875169.SGD","TTEQ","LU1732800096.USD","BK4533","LU1153585028.USD","LFGY","LU0170899867.USD","LU2746668461.USD","SPDN","BK4202","LU0175139822.USD","LU0265550359.USD","LU1035775433.USD","IE00BZ199S13.USD","LU2264538146.SGD","IXN","LU0648001328.SGD","LU1914381329.SGD","LU0648000940.SGD","BK4612","LU1935042215.USD","LU2764262908.HKD","LU0234572021.USD","LU0158827781.USD","LU0210533765.USD","RSPC","SGXZ99366536.SGD","LU0289960550.SGD","LU0342679015.USD","IE000SO60NU8.SGD","LU0690374961.EUR","METU","LU0417517546.SGD","LU1861220033.SGD","PYPY","LU0130518102.USD","IE00B19Z8W00.USD","LU1316542783.SGD","SCHX","LU2417539215.USD","LU0198837287.USD","LU2505996509.AUD","LU1564329628.SGD","LU1003077747.HKD","LU2360032135.SGD","IE0000B7K699.USD","LU0823421333.USD","LU3102509885.SGD","LU1670710588.SGD","LU1989772840.SGD","BK4097","LU0203201768.USD","SPYU","LU0130102774.USD","LU1670627923.USD","LU2028103732.USD","MRNY","LU0820561818.USD","LU0096362180.USD","IE00B19Z3B42.SGD","LU2089283258.USD","BK4535","LU1868837136.USD","LU0187121727.USD","SG9999015341.SGD","GB00B4QBRK32.GBP","CNEQ","LU0211328371.USD","BK4504","IE000W1ABFV2.USD","LU0203345920.USD","ABFL","LU1084165304.USD","LU2237443549.SGD","GXPC","IE0003U64NQ7.SGD","SMETAmain","GAMR","LU2242650005.HKD","LU2491050154.USD","LU2954938101.SGD","LU1261432733.SGD","LU1917777945.USD","LU1668664300.SGD","BK4558","YSPY","ARTY","BK4614","LU0082616367.USD","LU1242518931.SGD","BK4200","CLSE","LU0395794307.EUR","LU1674673691.USD","LU0689626769.HKD","LU0314104364.USD","LU1366192091.USD","PYPG","IE0001KFT4U8.USD","WCBR","LU0557290698.USD","NVDW","LU0553294199.USD","LU2106854487.HKD","LU0477156953.USD","SMAX","LU1564329032.USD","LU2322448791.USD","LU0345770308.USD","BK4550","LU0210536198.USD","LU1951200564.SGD","SOCL","SG9999002224.SGD","VGT","LU0265550946.USD","LU0070217475.USD","LU0124676726.USD","LTL","LU0138981039.USD","FTEC","HK0000304797.USD","LU0784385840.USD","TTXU","LU1852331112.SGD","IE00B775SV38.USD","GSLC","LU2168564065.EUR","LU1868837300.USD","SMH",".SPX","IE000YTNTUN2.SGD","LU2462157665.USD","LU1923623000.USD","HK0000819398.USD","IE00BJTD4N35.SGD","ALLW","LU0868494708.USD","METW","LU2461242641.AUD","NVDA","SPHQ","VV","ESLG","LU1629891620.HKD","LU2125154935.USD","LU2931357623.SGD","LU2250418816.HKD","NVDS","LU2272731782.SGD","BK4077","LU0323239441.USD","BK4524","IE00BQXX3F31.USD","LU0823421416.USD","2NVD.UK","LU0433182093.SGD","IE00BJLML261.HKD","LU2168564149.EUR","LU1815333072.USD","LU2361044949.HKD","LU2750360997.AUD","MOAT","LU0444971666.USD","LU0203347892.USD","LU1244550577.SGD","LU2473716301.USD","LU1674673428.USD","SG9999001077.SGD","BK4501","LU0208291251.USD","IE00BQXX3C00.GBP","LU2065170008.USD","LU1823568750.SGD","DMAX","LU1066053197.SGD","LU2746668974.SGD","LU0672654240.SGD","LU2552382215.SGD","IE00B4YYXB79.USD","IE00B5949003.HKD","LU2237957902.USD","LU2125909759.SGD","LU1201861249.SGD","LU1489326972.SGD","GPIX","LU0784385170.HKD","LU2065171402.SGD","LU1548497426.USD","ITOT","IE0004091025.USD","LU2764263203.CNY","LU0943347566.SGD","LU1868836757.USD","LU1571399168.USD","MRNX","LU1697837992.HKD","IE00BJJMRY28.SGD","VTI","HK0000306701.USD","LU0251132253.USD","IE00BJTD4V19.USD","IE000KEQY171.SGD","LU0787776722.HKD","LU2430703178.SGD","IE000BZT7R73.USD","LU0029864427.USD","IDNA","IE00B19Z9Z06.USD","LU0266013472.USD","07788","NVDD","LU0289961442.SGD","CHAT","LU2108987350.USD","CMAG","LU1861215975.USD","LU2191332357.HKD","LU0053666078.USD","LU1670711123.USD","LU0203202063.USD","IE00B3S45H60.SGD","SPHD","SHOC","LU0980610538.SGD","LU1496350171.SGD","DBSC","LU0965509101.SGD","LU0784384876.USD","LU2750360641.GBP","LU0072462426.USD","LU1821325948.USD","IE00BK4W5L77.USD","LU0788109477.HKD","HAKY","LU0234570918.USD","LU2125154778.USD","LU2133065610.SGD","LU1633808545.USD","LU1244550494.USD","SPYD","LU1861558580.USD","LU1880398471.USD","LU2237443978.SGD","NVII","BK4581","LU1116320737.USD","LGHT","MRNA","SPYV","LU0823414478.USD","SG9999018865.SGD","LU2290526834.HKD","LU0795875086.SGD","LU0072461881.USD","LU0289739343.SGD","AIFD","LU0158827948.USD","LU2237443895.HKD","IE00BYXW3230.USD","IE000MB6IJN5.SGD","LU0912757837.SGD","SPUS","BK4551","LU1791807156.HKD","IE000WAW04H5.SGD","IE0034235295.USD","LU1923622291.USD","LU2347655073.USD","METQ","LU1934455277.USD","LU2463028550.USD","LU2111349929.HKD","LU0708995401.HKD","LU0820562030.AUD","LU0345770993.USD","BK4608","LU1989764664.SGD","LU2413666426.HKD","LU1066051811.HKD","NOBL","EFIV","LU0957791311.USD","NVDX","LU2322448957.HKD","LU0157215616.USD","LU2720916845.USD","LU2602419157.SGD","LU1267930573.SGD","LU1267930813.SGD","VTV","LU0109392836.USD","METG","LU2471134523.USD","TEK","LU0868494617.USD","LU1923622614.USD","LU0320765489.SGD","LU1861127337.USD","LU0323591593.USD","LU0256863902.USD","GB00BDT5M118.USD","LU0738911758.USD","LU0823411888.USD","IE00B5TLWC47.USD","LU0820561909.HKD","LU1992135399.USD","LU0353189680.USD","SGXZ31699556.SGD","LU1732799900.SGD","LU1951198990.SGD","IE0004445239.USD","LU2244417387.USD","LU0323240290.USD","LU1066051225.USD","SOXY","LU0823434740.USD","LU0061474960.USD","BK4227","LU0130103400.USD","LU2023250843.SGD","SG9999015358.SGD","SGXZ80539844.SGD","IE00BD6J9T35.USD","LU2089985449.USD","LU2092627202.USD","LU0861579265.USD","IE00BMPRXQ63.HKD","LU2471134879.HKD","IE00B19Z9505.USD","LU0127658192.USD","SGXZ81514606.USD","BK4146","FBL","BK4505","MMAX","LU2065171311.SGD","SMHX","LU1244550221.USD","BK4587","LU2023251221.USD","LU2491049909.HKD","BK4588","LU0109391861.USD","LU1935042488.USD","METV","LU2430703095.HKD","LU1880398554.USD","HIBS","XDTE","LU0308772762.SGD","LU0106831901.USD","NVD2.UK","LU2294711713.HKD","LU1861559042.SGD","LU2462591277.SGD","LU0215105999.USD","IE0004445015.USD","LU0466842654.USD","LU2360107168.USD","SG9999015986.USD","LU0784383803.USD","IE00BYQQ9H92.USD","LU2360107671.USD","FAI","LU1366333091.USD","LU2087621335.USD","NULC","LU1712237335.SGD","LU2433249047.HKD","LU2097344431.USD","BK4532","LU0048573561.USD","LU1074936037.SGD","LU1988902786.USD","BMAY","IJH","JGRO","LU1145028129.USD","IVV","LU1974910355.USD","LU0957808578.USD","LU2420271590.USD","LU0545039389.USD","IE00BDCRKT87.USD","SG9999015952.SGD","BK4538","IE000ITXATA3.USD","LU1127390331.HKD","BK4613","SG9999014559.SGD","LU0949170426.SGD","NVDG","LULG","LU1989772923.USD","XLC","SG9999014567.USD","LU1989764748.USD","LU2357305700.SGD","LU0080751232.USD","LU0985320562.USD","LU1551013342.USD","LU1718418525.SGD","SG9999017495.SGD","SPXS","LU2860962120.EUR","IE00BMPRXR70.SGD","IE00B7SZLL34.SGD","LU0742534661.SGD","LU0225283273.USD","LU0354030438.USD","BK4554","HK0000304805.HKD","IE000Q6AESB8.SGD","IE00BJJMRX11.SGD","LU0068578508.USD","LU0642271901.SGD","IE00BFSS8Q28.SGD","LU2092937148.SGD","SG9999014575.USD","TRUC","LU2361045086.USD","LU0444973449.USD","HK0000914660.USD","VOOG","AGOX","LU1868836591.USD","XLG","IE00BDRTCR15.USD","NVD3.UK","LU2236285917.USD","IE0002270589.USD","IE000F7OJYX1.SGD","LU1066051498.USD","IE00B1BXHZ80.USD","LU1670711040.USD","IE00BKPKM429.USD","LU0965509283.SGD","LU0979878070.USD","LU1979441026.SGD","LU2087625088.SGD","LU1144417596.USD","IE00B7KXQ091.USD","LU0476273544.USD","WISE","LU0057025933.USD","NVDU","LU1934455194.USD","LU0511384066.AUD","BK4566","SPGP","IE00BHPRN162.USD","LU2247934214.USD","LU1791710582.SGD","LU1814569148.SGD","LU2047632596.USD","LU0096364046.USD","LU0985489474.SGD","SNPE","LU1868836914.USD","LU2381873111.SGD","LU0267386448.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663182230","title":"Incyte Corp Drops in Volume Surge, Last Down 3.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663182230","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663182230?lang=en_us&edition=fundamental","pubTime":"2026-08-29 02:50","pubTimestamp":1787943046,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL6N44P0ZO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4550","BK4585","INCY","BK4532","BK4588","IDNA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663018217","title":"BioNTech Stock Falls on Cancer Vaccine Setback Days After Moderna's Big Win","url":"https://stock-news.laohu8.com/highlight/detail?id=2663018217","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663018217?lang=en_us&edition=fundamental","pubTime":"2026-08-29 02:44","pubTimestamp":1787942640,"startTime":"0","endTime":"0","summary":"BioNTech stock fell sharply on Friday after the company announced it had scrapped a clinical trial for its mRNA cancer vaccine, marking the second setback in months.The German biotech and partner Gene","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MRNA","BK4535","BK4551","BK4585","BK4568","BK4534","BK4501","IDNA","BK4532","GNOM","BK4533","BK4548","WDNA","BNTX","BK4588","MRNX","MRNY","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663097770","title":"BioNTech on Track for Worst Day Since March After Ending Colorectal Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2663097770","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663097770?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:46","pubTimestamp":1787935618,"startTime":"0","endTime":"0","summary":"BUZZ-BioNTech on track for worst day since March after ending colorectal cancer trialUpdates** U.S.-listed shares of German drugmaker BioNTechBNTX.O22UAy.DEfall 7.4% to $103.07, putting the stock on c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL4N44P1BJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNOM","MRNX","BK4588","BK4501","BK4139","BK4585","BK4568","BK4533","BK4551","MRNY","IDNA","BK4532","WDNA","BNTX","MRNA","BK4534","BK4548","LGHT","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663097210","title":"Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663097210","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663097210?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:30","pubTimestamp":1787934634,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals Inc. ($VRTX) announced an update on their ongoing clinical study. Vertex’s new Phase 1 study, officially titled “A Phase 1, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-tests-vx-407s-impact-on-birth-control-what-it-means-for-vrtx-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-tests-vx-407s-impact-on-birth-control-what-it-means-for-vrtx-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2089984988.USD","LU1674673428.USD","LU2324357040.USD","SG9999013999.USD","LU0417517546.SGD","ISBC","IBBQ","LU2237438978.USD","SG9999001176.SGD","SG9999001176.USD","BIB","LU2362540622.SGD","PBE","BK4588","BK4139","LU1559883803.SGD","BK4567","LU0889565916.HKD","BBH","BK4532","IE00B894F039.SGD","LU0058720904.USD","LU2468319806.SGD","LU1815336091.USD","IE00B19Z3581.USD","LU1585245621.USD","VRTX","BK4023","LU2362541273.HKD","GNMX","BK4211","LU0566484027.USD","IE0002270589.USD","LU0823416689.USD","TBXU","IE00BZ9MQY76.HKD","LU2417539215.USD","SGXZ57979304.SGD","LU1430594728.SGD","IE00BJT1NW94.SGD","LU1093756325.SGD","BK4585","IE00B2B36J28.USD","IE00B19Z9Z06.USD","VERX","LU2362541513.USD","IDNA","IE0009355771.USD","LU0320765992.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663975310","title":"Revolution Medicines Set to Post 'Strong Launch' for Rasonque, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2663975310","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663975310?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:18","pubTimestamp":1787933923,"startTime":"0","endTime":"0","summary":"Revolution Medicines  should post \"strong launch numbers\" for pancreatic cancer drug Rasonque , which would serve as a key driver of its 2026 and 2027 revenue, UBS Securities said in a Thursday note.The US Food and Drug Administration approved Rasonque for the treatment of adult patients with metastatic pancreatic adenocarcinoma, with the company to price the therapy at $39,800 for a 30-day supply.Street consensus for the company's 2026 and 2027 revenue already increased following the approval, but the updated projections remain achievable, UBS said. Revolution Medicines already had 2,000 patients on its expanded access program as of Q2, the brokerage noted.The consensus is for $152 million revenue in 2026 and $1.10 billion in 2027, while UBS estimates $193 million in 2026 and $1.91 billion in 2027, according to the note.UBS also noted the upcoming phase 3 data on daraxonrasib in non-small cell lung cancer by year-end 2027 as Revolution Medicines' next major clinical catalyst.UBS raise","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BFTCPJ56.SGD","IE00B2B36J28.USD","BBH","IE00B4R5TH58.HKD","IE0002141913.USD","IE00BJJMRZ35.SGD","IE0009354923.USD","LU0109394709.USD","IDNA","IE00BJT1NW94.SGD","LU0320765992.SGD","LU0889565916.HKD","BK4139","IE0009355771.USD","PTH","RVMD","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662094399","title":"mRNA immunotherapy discontinuation a negative for BioNTech, says Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2662094399","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662094399?lang=en_us&edition=fundamental","pubTime":"2026-08-28 22:55","pubTimestamp":1787928925,"startTime":"0","endTime":"0","summary":"After BioNTech (BNTX) announced the discontinuation of its Phase 2 study partnered with Roche (RHHBY) of autogene cevumeran, an individualized mRNA...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mrna-immunotherapy-discontinuation-a-negative-for-biontech-says-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mrna-immunotherapy-discontinuation-a-negative-for-biontech-says-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","BK4588","BK4139","BNTX","BK4007","BK4548","03165","HRTS","BK4551","IDNA","CANC","BK4535","RHHBY","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662091557","title":"Moderna Stock Falls on $2B Notes Deal: Is the Cancer Rally Still Intact?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662091557","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662091557?lang=en_us&edition=fundamental","pubTime":"2026-08-28 22:00","pubTimestamp":1787925600,"startTime":"0","endTime":"0","summary":"TradingKey - MRNA closed at $142.77 after a $2B convertible-notes plan. Phase 3 melanoma success is powerful, but dilution and cash burn raise the stakes for investors.\n","market":"us","thumbnail":"https://resource.tradingkey.com/uploads/20260510/Moderna-288a1cc7991e4f03bba2bb41856a0806.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260510/Moderna-288a1cc7991e4f03bba2bb41856a0806.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/262138360-moderna-stock-2b-notes-cancer-vaccine-rally-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4568","MRNX","BK4534","BK4533","BK4532","BK4501","MRNA","BK4548","BK4139","GNOM","IDNA","MRNY","WDNA","BK4551","BK4588","LGHT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}